Top Health Care Stocks
Health care stocks were posting moderate gains during afternoon trade, with the NYSE Health Care Index increasing about 0.5% while shares of health care companies in the S&P 500 also were up about 0.5% as a group.
In company news, Ariad Pharmaceuticals ( ARIA ) Monday was ending just under its best share price since March 2000 after the oncology-drug company agreed to a $5.2 billion buyout offer from Japanese rival Takeda.
Under terms of the proposed transaction, Takeda would pay $24 per share in cash, or just under 75% over Friday's closing price of $13.75 a share. Takeda described the deal as "compelling," saying it believed the acquisition would immediately increase its net income and revenue after closing, including Ariad's prior guidance expecting between $170 million to $180 million in revenue during 2017 from sales of its Iclusig cancer medication for adults with a certain abnormal gene.
The companies are expecting to complete the deal by Feb. 28.
ARIA shares were up almost 73% at $23.74 apiece, or just 7 cents under a nearly 17-year high of $23.81 a share.
In other sector news,
(+) ETRM, Files amended S-1 registration statement, reducing the number of Class A units to be offered by 31% to 604,535 units and all but 9,600 Class B units compared with 3.25 mln in original prospectus.
(-) AMAG, Agrees to pay $60 mln upfront payment to Palatin Technologies ( PTN ) in exchange for exclusive North American rights to commercialize Rekynda, a prospective treatment for hypoactive sexual desire disorder in adult women.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.